Clinical Trials Directory

Trials / Completed

CompletedNCT04577716

Predicting Endoleaks Following Endovascular Aortic Aneurysm Repair Using 18F-Sodium Fluoride

The PET-EVAR Study - Predicting Endoleaks Following Endovascular Aortic Aneurysm Repair Using 18F-Sodium Fluoride

Status
Completed
Phase
Study type
Observational
Enrollment
102 (actual)
Sponsor
University of Edinburgh · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to describe Sodium Fluoride uptake (using Positron Emission Tomography-Computed Tomography - PET-CT) following Endovascular Aneurysm Repair (EVAR) and to determine whether Sodium Fluoride PET-CT can predict the development of endoleaks.

Detailed description

Abdominal aortic aneurysms are a leading cause of death in the United Kingdom. Surveillance programmes and pre-emptive surgical repair are lifesaving. Traditional open surgical repair is associated with major perioperative morbidity and mortality and there has been a move towards minimally invasive Endovascular Aneurysm Repair (EVAR), which reduces these early risks. However, the cost effectiveness and long-term clinical effectiveness of EVAR is undermined by concerns of durability due to the development of endoleaks and late aneurysm rupture secondary to progression of native aortic aneurysm disease and stent graft failure. It has previously been demonstrated that 18F-Sodium Fluoride Positron Emission Tomography can predict progression of aneurysm disease and is associated with greater rates of abdominal aortic aneurysm expansion and the future risk of rupture or surgical repair. The investigators here wish to examine whether 18F-Sodium Fluoride on Positron Emission Tomography uptake (i) is increased in patients with endoleaks or related complications, (ii) can prospectively predict the likelihood of developing endoleaks in patients undergoing EVAR, and (ii) is a feasible approach to select patients for EVAR with a reduced future risk of stent graft failure and re-intervention. The investigators believe that there is a compelling scientific rationale for this approach with major translational potential to better select subgroups of patients for EVAR and ultimately improve their outcome.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TEST18F Sodium Fluoride Positron Emission Tomography / Computed TomographyPET scan using the 18F-Sodium Fluoride radiotracer followed by an attenuation correction CT scan
DIAGNOSTIC_TESTCT Aortic AngiogramCT scan to assess aortic morphology and contextualise PET scan
DIAGNOSTIC_TEST12-month CT Aortic AngiogramCT scan to assess aortic morphology and the stent graft
OTHER24-month reviewThis will consist of a telephone consultation with the study participant and review of electronic clinical records

Timeline

Start date
2021-04-01
Primary completion
2025-03-31
Completion
2025-03-31
First posted
2020-10-08
Last updated
2025-07-03

Locations

4 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04577716. Inclusion in this directory is not an endorsement.